Clicky

Fluidigm Corporation(FLB)

Description: Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.


Keywords: Biotechnology Cancer Imaging Antibodies Software Services Genomics Laboratory Techniques Mass Spectrometry Proteomics Microfluidics Ifc Analytical Systems California Institute Of Technology Harvard University Mass Cytometry

Home Page: www.standardbio.com

2 Tower Place
South San Francisco, CA 94080
United States
Phone: 650 266 6000


Officers

Name Title
Dr. Michael Egholm Ph.D. President, CEO & Director
Mr. Hanjoon Kim Chief Financial Officer
Mr. Jonathan Mickelsen VP & Chief Accounting Officer
David Holmes Investor Relations
Mr. Sean Mackay Chief Business Officer & Senior VP
Dr. Stephen A. Williams BS, MB, Ph.D. Chief Medical Officer

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.3207
Price-to-Sales TTM: 3.9978
IPO Date:
Fiscal Year End: December
Full Time Employees: 534
Back to stocks